ec1.5x

Fluconazole-C15-XMU-MP-9 is a fluconazole derivative modified with XMU-MP-9, which enhances the interaction between Nedd4-1 and K-Ras, promoting the ubiquitination and degradation of multiple K-Ras mutants, demonstrating anticancer potential. Fluconazole is an antifungal agent.

RG7800 hydrochloride is an orally active modulator of SMN2 splicing.

FXIa-IN-15 (Compound (S)-10h) is an inhibitor of factor XIa (FXIa) and plasma kallikrein (PKa) with IC50 values of 0.38 nM and 59.2 nM, respectively. It exhibits anticoagulant properties by prolonging the 50% activated partial thromboplastin time (aPTT) with an EC1.5X of 0.55 μM.

RG7800 hydrochloride is an orally active SMN2 splicing modulator that acts on SMN2 splicing (EC1.5x: 23 nM) and SMN proteins (EC1.5x: 87 nM).

RG7800 hydrochloride is an orally active SMN2 splicing modulator with EC50 values of 23 nM for splicing and 87 nM for SMN protein production, holding promise as a therapeutic agent for [spinal muscular atrophy].